Affimed’s (AFMD) “Equal Weight” Rating Reaffirmed at Wells Fargo & Company
Affimed (NASDAQ:AFMD – Get Free Report)‘s stock had its “equal weight” rating reiterated by research analysts at Wells Fargo & Company in a research note issued on Tuesday,Benzinga reports. They presently have a $0.10 target price on the biopharmaceutical company’s stock, down from their previous target price of $11.00. Wells Fargo & Company‘s target price […]
Affimed (NASDAQ:AFMD – Get Free Report)‘s stock had its “equal weight” rating reiterated by research analysts at Wells Fargo & Company in a research note issued on Tuesday,Benzinga reports. They presently have a $0.10 target price on the biopharmaceutical company’s stock, down from their previous target price of $11.00. Wells Fargo & Company‘s target price […]
